The integration of artificial intelligence (AI) chatbots into clinical trials offers a transformative approach to collecting patient-reported outcomes (PROs). Despite the increasing use of AI chatbots
Data from Review of Symptoms Form, Version 2: Gastrointestinal [CRF 6] Study Description Suboptimal response to hepatitis B vaccination in HIV-positive adults and children has been well documented in
